Loading
Latest filing published 24 Oct 2026 for Hapbee Technologies, Inc., €457k.
No signal scores available.
This profile gathers the share dealings of EMulate Therapeutics, Inc. in Hapbee Technologies, Inc. Over a trading history stretching from 26 October 2020 to 22 January 2025, the count stands at 3 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The latest filing, published on 24 October 2026, reports a transaction of €457k in Hapbee Technologies, Inc. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations